The latest pancreatic cancer news
Johns Hopkins Medicine scientists (USA) say they have found a pattern of so-called epigenetic “marks”…
On March 26, 2025, the Food and Drug Administration approved cabozantinib (Cabometyx, Exelixis, Inc.) for…
Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related mortality worldwide. Current treatment…
A new study led by UCLA investigators suggests that chronic stress and an unhealthy diet…
A new study by Mayo Clinic Comprehensive Cancer Centre researchers found that the presence of a specific…
Pancreatic cancer is one of the deadliest cancers worldwide, with a five-year survival rate of…
Adding immunotherapy to a new type of inhibitor that targets multiple forms of the cancer-causing…
The discovery of a ‘biomarker panel’ could have a profound impact on the ability to…
A new review article has highlighted the crucial role of GATA6, a transcription factor, in…
A new blood test could help doctors detect pancreatic cancer earlier, potentially improving survival rates…